NIH-funded research NIH-funded research

Developing new contraceptive products for men and women

Official title: BIOLOGICAL TESTING FACILITY (BTF) - PRECLINICAL DEVELOPMENT OF CONTRACEPTIVE PRODUCTS

Funded at Sri International · NIH-11193553 · Data updated 2026-11-12

This study is exploring new and safe ways to prevent pregnancy by looking at different compounds that can affect ovulation and sperm function, and it's designed for anyone interested in better contraceptive options.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSri International
NIH-funded
Lab location1 site (Menlo Park, United States)
Project startSeptember 27, 2024
Project endSeptember 26, 2026
Funding year2024
Award (this year)$1,017,684
NIH project number75N94020D00003-0-759402400002-1
Project IDNIH-11193553 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals interested in new contraceptive options, particularly those who may not find current methods suitable.

Less likely to help

Patients who are not seeking contraceptive solutions or those who have contraindications to hormonal or chemical contraceptives may not benefit from this research.

What this research studies

This research focuses on creating safe and effective contraceptive methods by investigating compounds that can disrupt reproductive processes such as ovulation and sperm function. The Biological Testing Facility (BTF) will evaluate new and existing chemical formulations, drug delivery systems, and devices aimed at contraception. Through various testing methods, including laboratory and animal studies, the project aims to gather data necessary for regulatory approval of new contraceptive options.

Why it matters

Potential benefit: If successful, this research could lead to innovative contraceptive methods that provide more choices and improved safety for individuals seeking to prevent pregnancy.

How similar studies have gone: Previous research in contraceptive development has shown promise, indicating that innovative approaches can lead to successful new contraceptive methods.

Where this research is happening

  • Sri International
    Menlo Park, United States
    Active

Researchers

  • Principal investigator: Burnin, Debra — Sri International
  • Study coordinator: Burnin, Debra

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.